The chip challenge
This issue is accompanied by The Chipping Forecast, a collection of articles describing different aspects of microarray (or DNA-chip) analysis and challenges facing this young but fast-growing technology. The National Human Genome Research Institute (NHGRI) of the National Institutes of Health has sponsored the supplement with the hope that-as Francis Collins, the Institute's director, puts it-"the technology of microarrays will be opened up and demystified, and . . . additional opportunities for creative exploration will be catalysed." Indeed, the supplement was conceived upon realizing that, despite a wealth of reviews and a great deal of professed interest from our readers, there was no single source of information from which investigators could derive the kind of information they would require to approach the technology.
The supplement aims to explore the microarray from different angles. Edwin Southern and colleagues (Oxford University) review current knowledge of the hybridization reaction, which lies at the core of array methodology, and describe how microarray analysis can be used to further elucidate properties of the reaction. Jeffrey Trent and colleagues (NHGRI), and Robert Lipshutz and colleagues (Affymetrix) provide the reader with overviews of spotting and photolithographic methods, respectively, for making arrays. The number of commercially available options appears to have increased dramatically over the last year; David Bowtell (Peter MacCallum Cancer Institute) provides information on some of these. A 'nuts and bolts' appreciation of how a spotting arrayer and scanner are built and how spotting arrays are processed helps one to understand the principles underlying the different procedures, and equips those contemplating the 'do-it-yourself ' approach. Vivian Cheung (University of Pennyslvania) and Geoff Childs (Albert Einstein College of Medicine) provide a detailed account, based on experience in their own laboratories. While it is often said that the proof of the pudding is in the eating, digestion plays a critical role in determining what good may be derived from it. As Jeffrey Trent-whose input into the entire supplement is gratefully acknowledgedpoints out, to achieve true knowledge of genome function, biologists will "need to recruit statisticians and mathematicians to consider multivariant problems of a size never before encountered." Mark Boguski (National Center for Biotechnology Information) and colleagues discuss the challenges of making sense of the vast quantities of data generated by microarray analyses, which include the need for suitable software and database systems to design arrays, track materials and collect, analyse and interpret information. Several articles focus on applications and biological parameters that may critically affect the success of analysis. Michael Emmert-Buck and colleagues (National Cancer Institute) discuss aspects of sample selection and preparation, and describe one approach to integrating expression data. Joe Hacia (NHGRI) discusses the strengths and weaknesses of the technology for mutation detection, while Christine Debouck and Peter Goodfellow (SmithKline Beecham Pharmaceuticals) speculate on how microarray analysis will affect drug development. The utility of arrays in exploring the 'next frontier'-charting and making sense of the tides and undercurrents that shape the human genome over time and space-is discussed by Aravinda Chakravarti (Case Western Reserve University).
As Eric Lander (Whitehead Institute) points out in his perspective, the primary challenge will be to find ways to infer causation from correlation-which is not a new problem, although its magnitude is. Array-based approaches have been criticized for not being hypothesis-driven, an argument previously used to decry largescale mutagenesis screens and genome sequencing efforts. While predominantly descriptive and exploratory in nature, these projects have lead to the formulation of a large number of scientific hypotheses, many of which are now being tested. Array analyses will similarly provoke new hypotheses; see, for example, the study reporting mutations in Cd36 in a hypertensive rat model, by Timothy Aitman and colleagues on page 76 of this issue.
In their article that focuses on dissection of biological systems, Patrick Brown and David Botstein (Stanford University) suggest that "exploration of the new world of the genome will present novel challenges to scientific publishing." They propose that, in response to the exploratory nature of research that capitalizes on extended sequence data and the power of microarray analysis, journals must become less focused on the 'bottom line' of a paper and accommodate the publication of large, descriptive data sets. While handling large datasets presents a challengefor journals and researchers alikearray data do not fundamentally differ from those generated say, by large-scale mutagenesis screens. The description of patterns, whether generated by monitoring gene expression or disruption of normal development, represents an important step towards understanding principles underlying the generation of pattern. While journals (and reviewers) might like papers with a 'bottom line' , there is no rule against descriptive studies. Decisions on the suitability of a particular manuscript for publication are based on accuracy, significance, novelty and expected impact of the results reported.
Admittedly, array data are of a magnitude unprecedented in biology. Fortunately, accessory electronic space on most journals' web sites is either available or imminent, but the real question is whether microarray data are suitable for publication in the conventional sense-as printed figures and tables or as supplementary electronic information. They might be more comparable to sequence data, which are commonly published by referring to accession numbers. In their article, Mark Boguski and co-authors outline their vision of a public depository for expression data. While its realization will not be straightforward, a centralized database is necessary, and its development will depend upon and perhaps help to resolve critical issues, such as the need for standardization.
Apart from exhibition of the raw data, discussion of rationale and conclusions is an essential part of scientific communication. Journals have historically been places for discourse as well as data presentation; readers don't just look at figures and read methods, they evaluate approach and conclusions. While entire data sets from large-scale high-throughput analyses might be better placed in a database, their public discourse remains important, particularly in a field that depends critically on interaction between disciplines. The advent of microarray data thus presents a challenge to geneticists, bioinformaticians and editors, but there is no reason to suggest that we need to invent new paradigms for their publication.
